Document:

EX-10.10

 Exhibit 10.10 

SUBSCRIPTION AGREEMENT 

This Subscription Agreement (this “Agreement”) is made as of June 11, 2021 by and among: 

 

	 	(1)	 Soulgate Inc., an exempted company incorporated under the laws of the Cayman Islands (the
“Company”); and 

  

	 	(2)	 MIHOYO LIMITED, a company incorporated in Hong Kong (the “Purchaser”). The Purchaser on the
one hand, and the Company on the other hand, are sometimes herein referred to each as a “Party,” and collectively as the “Parties.” 

W I T N E S S E T H: 

WHEREAS, the Company publicly filed a registration statement on Form F-1 on May 10, 2021 (as may
be amended from time to time, the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”) in connection with the initial public offering (the “Offering”) by
the Company of American Depositary Shares (“ADS”) representing Class A ordinary shares of par value US$0.0001 per share, (“Class A Ordinary Shares”) of the Company as specified in the
Registration Statement; and 
 WHEREAS, the Purchaser wishes to invest in the Company by acquiring Class A Ordinary Shares in the
Company in a transaction exempt from registration pursuant to Regulation S (“Regulation S”) of the U.S. Securities Act of 1933, as amended (the “Securities Act”); 

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, the Parties hereto agree as follows:

 ARTICLE I 

PURCHASE AND SALE 

Section 1.1 Issuance, Sale and Purchase of Class A Ordinary Shares. Upon the terms and subject to the
conditions of this Agreement, the Purchaser hereby agrees to purchase, and the Company hereby agrees to issue, sell and deliver to the Purchaser, at the Closing (as defined below), such number of Class A Ordinary Shares that is equal to the
quotient of the Purchase Price (as defined below) divided by the Offer Price (as defined below) (the “Purchased Shares”) at a price per Ordinary Share equal to the Offer Price and for an aggregate purchase price of US$88,880,000
(the “Purchase Price”), free and clear of all liens or encumbrances (except for restrictions arising under the Securities Act or created by virtue of this Agreement or the Lock-up Agreement
(as defined below)); provided, however, that (a) no fractional shares of Class A Ordinary Shares will be issued as Purchased Shares, (b) any fractions shall be rounded down to the nearest whole number of Class A
Ordinary Shares, and (c) the Purchase Price will be reduced by the value of any such fractional share (as calculated on the basis of the Offer Price). The “Offer Price” means the price per ADS set forth on the cover of the
Company’s final prospectus in connection with the Offering divided by the number of Class A Ordinary Shares represented by one ADS. The purchase, issuance, sale and delivery of the Purchased Shares shall be made pursuant to and in reliance
upon Regulation S. 

  
 1 

 Section 1.2 Closing. 

(a) Closing. Subject to Section 1.3, the closing (the “Closing”) of the sale and purchase of
the Purchased Shares pursuant to Section 1.1 shall take place concurrently with the closing of the Offering at the same offices for the closing of the Offering or at such other place as the Company and the Purchaser may
mutually agree with respect to the Purchased Shares. The date and time of the Closing are referred to herein as the “Closing Date.” 

(b) Payment and Delivery. At the Closing, the Purchaser shall pay and deliver the Purchase Price to the Company in U.S. dollars by wire
transfer, or by such other method mutually agreeable to the Company and the Purchaser, of immediately available funds to such bank account designated in writing by the Company, and the Company shall deliver one or more duly executed share
certificates in original form, registered in the name of the Purchaser, together with a certified true copy of the register of the members of the Company, evidencing the Purchased Shares being issued and sold to the Purchaser. 

(c) Restrictive Legend. The certificate representing Purchased Shares shall be endorsed with the following legend: 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (AS AMENDED, THE “ACT”) OR UNDER THE SECURITIES LAWS OF
ANY STATE. THIS SECURITY MAY NOT BE TRANSFERRED, SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED: (A) IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, (2) AN EXEMPTION OR QUALIFICATION UNDER THE ACT AND OTHER
APPLICABLE SECURITIES LAWS OR (3) DELIVERY TO THE COMPANY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED; AND (B) WITHIN THE UNITED STATES OR TO ANY U.S. PERSON, AS EACH OF THOSE
TERMS IS DEFINED IN REGULATION S UNDER THE ACT, DURING THE 40 DAYS FOLLOWING CLOSING OF THE PURCHASE. ANY ATTEMPT TO TRANSFER, SELL, PLEDGE OR HYPOTHECATE THIS SECURITY IN VIOLATION OF THESE RESTRICTIONS SHALL BE VOID. 

Section 1.3 Closing Conditions. 

(a) Conditions to the Purchaser’s Obligations to Effect the Closing. The obligation of the Purchaser to purchase and pay for the
Purchased Shares as contemplated by this Agreement is subject to the satisfaction, on or before the Closing Date, of the following conditions, any of which may only be waived in writing by the Purchaser in its sole discretion: 

(i) All corporate and other actions required to be taken by the Company in connection with the issuance, sale and delivery of
the Purchased Shares shall have been completed. 

  
 2 

 (ii) The representations and warranties of the Company to the Purchaser
contained in Section 2.1 of this Agreement shall have been true and correct in all material respects on the date of this Agreement and true and correct in all material respects on and as of the Closing Date (except the
representations and warranties contained in Section 2.1(i) shall be true and correct in all respects on and as of the Closing Date); and the Company shall have performed and complied in all material respects with all, and
not be in breach or default in any material respects under any, agreements, covenants, conditions and obligations contained in this Agreement that are required to be performed or complied with on or before the Closing Date. 

(iii) No governmental authority of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any law
(whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, prevents, prohibits or otherwise makes illegal the consummation of the transactions contemplated by this Agreement with respect to the Purchaser, or imposes any
damages or penalties in connection with the transactions contemplated by this Agreement with respect to the Purchaser that are substantial in relation to the Company; and no action, suit, proceeding or investigation shall have been instituted by a
governmental authority of competent jurisdiction or threatened that seeks to restrain, enjoin, prevent, prohibit or otherwise make illegal the consummation of the transactions contemplated by this Agreement with respect to the Purchaser, or imposes
any damages or penalties in connection with the transactions contemplated by this Agreement with respect to the Purchaser that are substantial in relation to the Company. 

(iv) The Offering shall have been, or shall concurrently with the Closing be, completed. 

(v) The ADSs shall have been listed on the Nasdaq Stock Market subject to official notice of issuance. 

(vi) The underwriting agreement relating to the Offering shall have been entered into and have become effective. 

(b) Conditions to Company’s Obligations to Effect the Closing. The obligation of the Company to issue and sell the Purchased Shares
to the Purchaser as contemplated by this Agreement is subject to the satisfaction, on or before the Closing Date, of each of the following conditions, any of which may be waived in writing by the Company in its sole discretion: 

(i) The Lock-up Agreement shall have been executed and delivered by the Purchaser to
the representatives of the underwriters for the Offering. 
 (ii) All corporate and other actions required to be taken by the
Purchaser in connection with the purchase of the Purchased Shares shall have been completed. 
 (iii) The representations and
warranties of the Purchaser contained in Section 2.2 of this Agreement shall have been true and correct on the date of this Agreement and in all material respects on and as of the Closing Date; and the Purchaser shall have
performed and complied in all material respects with all, and not be in breach or default in any material respect under any, agreements, covenants, conditions and obligations contained in this Agreement that are required to be performed or complied
with on or before the Closing Date. 

  
 3 

 (iv) No governmental authority of competent jurisdiction shall have enacted,
issued, promulgated, enforced or entered any law (whether temporary, preliminary or permanent) that is in effect and restrains, enjoins, prevents, prohibits or otherwise makes illegal the consummation of the transactions contemplated by this
Agreement with respect to the Purchaser, or imposes any damages or penalties in connection with the transactions contemplated by this Agreement with respect to the Purchaser that are substantial in relation to the Company; and no action, suit,
proceeding or investigation shall have been instituted by a governmental authority of competent jurisdiction or threatened that seeks to restrain, enjoin, prevent, prohibit or otherwise make illegal the consummation of the transactions contemplated
by this Agreement with respect to the Purchaser, or imposes any damages or penalties in connection with the transactions contemplated by this Agreement with respect to the Purchaser that are substantial in relation to the Company. 

ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Section 2.1 Representations and Warranties of the Company. The Company hereby represents and warrants to the Purchaser, as of the
date hereof and as of the Closing Date, as follows: 
 (a) Due Formation. The Company is a company duly incorporated as an exempted
company with limited liability, validly existing and in good standing under the laws of the Cayman Islands. The Company has all requisite power and authority to carry on its business as it is currently being conducted. 

(b) Authority. The Company has full power and authority to enter into, execute and deliver this Agreement and each agreement,
certificate, document and instrument to be executed and delivered by the Company pursuant to this Agreement and to perform its obligations hereunder. The execution and delivery by the Company of this Agreement and any agreements, certificates,
documents and instruments to be executed and delivered by the Company pursuant to this Agreement, and the performance by the Company of its obligations hereunder, have been duly authorized by all requisite actions on its part. 

(c) Valid Agreement. This Agreement has been duly executed and delivered by the Company and constitutes the legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of
creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. 

(d) Capitalization. 

  
 4 

 (i) The share capital of the Company (the “Company
Capitalization”) as of the date hereof is as set forth in Schedule A of this Agreement. All issued and outstanding ordinary shares and preferred shares of the Company are validly issued, fully paid, and
non-assessable. The Company Capitalization as of the Closing shall be as set forth in the Registration Statement. 

(ii) All outstanding share capital of the Company (including Class A Ordinary Shares), and all outstanding share capital
of each of the Company’s subsidiaries and consolidated affiliates (each a “Subsidiary” and collectively “Subsidiaries”) have been issued in compliance with (x) all applicable Securities Laws and other
applicable laws and (y) all requirements set forth in applicable contracts, without violation of any preemptive rights, rights of first refusal or other similar rights. “Securities Laws” means the Securities Act, the Securities
Exchange Act of 1934, as amended, the listing rules of, or any listing agreement with the Nasdaq Stock Market and any other applicable law regulating securities or takeover matters. 

(iii) The rights of the Class A Ordinary Shares to be issued to the Purchaser as Purchased Shares are as stated in the
Sixth Amended and Restated Memorandum and Articles of Association of the Company as set out in Exhibit 3.2 of the Registration Statement, which is conditionally adopted by the shareholders of the Company and will become effective immediately prior
to the completion of the Offering. 
 (e) Due Issuance of the Purchased Shares. The Purchased Shares have been duly authorized and,
when issued and delivered to and paid for by the Purchaser pursuant to this Agreement, will be validly issued, fully paid and non-assessable and free and clear of any pledge, mortgage, security interest,
encumbrance, lien, charge, assessment, right of first refusal, right of pre-emption, third party right or interest, claim or restriction of any kind or nature, except for restrictions arising under the
Securities Act or created by virtue of this Agreement or the Lock-up Agreement and upon delivery and entry into the register of members of the Company will transfer to the Purchaser good and valid title to the
Purchased Shares. 
 (f) Noncontravention. Neither the execution and the delivery of this Agreement, nor the consummation of the
transactions contemplated hereby, will (i) violate any provision of the organizational documents of the Company or its Subsidiaries or violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or
other restriction of any government, governmental entity or court to which the Company or its Subsidiaries is subject, or (ii) conflict with, result in a breach of, constitute a default under, result in the acceleration of or creation of an
encumbrance under, or create in any party the right to accelerate, terminate, modify, or cancel, any agreement, contract, lease, license, instrument, or other arrangement to which the Company or its Subsidiaries is a party or by which the Company or
its Subsidiaries is bound or to which any of the Company’s or its Subsidiaries’ assets are subject. There is no action, suit or proceeding, pending or threatened against the Company or its Subsidiaries that questions the validity of this
Agreement or the right of the Company to enter into this Agreement or to consummate the transactions contemplated hereby. 
 (g) Consents
and Approvals. Neither the execution and delivery by the Company of this Agreement, nor the consummation by the Company of any of the transactions contemplated hereby, nor the performance by the Company of this Agreement in accordance with its
terms requires the consent, approval, order or authorization of, or registration with, or the giving notice to, any governmental or public body or authority or any third party, except such as have been or will have been obtained, made or given on or
prior to the Closing Date. 

  
 5 

 (h) Compliance with Laws. Except, as of the date hereof, as disclosed in the
Registration Statement, and as of the Closing Date, as disclosed in the Registration Statement in the form then declared effective by the SEC, the business of the Company or its Subsidiaries is not being conducted in violation of any law or
government order applicable to the Company except for violations which do not and would not have a Material Adverse Effect. As used herein, “Material Adverse Effect” shall mean any event, fact, circumstance or occurrence that,
individually or in the aggregate with any other events, facts, circumstances or occurrences, results in or would reasonably be expected to result in a material adverse change in or a material adverse effect on (i) the financial condition,
assets, liabilities, results of operations, business, or operations of the Company or its Subsidiaries taken as a whole, except to the extent that any such Material Adverse Effect results from (x) changes in generally accepted accounting
principles that are generally applicable to comparable companies or (y) changes in general economic and market conditions; or (ii) the ability of the Company to consummate the transactions contemplated by this Agreement and to timely
perform its obligations under the Agreement. 
 (i) SEC Filings. Prior to the Closing, the Registration Statement, as supplemented or
amended, shall have been declared effective by the SEC. The Registration Statement, including the prospectus therein, conforms and will conform, in all material respects to the requirements of the Securities Act and the rules and regulations of the
SEC thereunder and does not, as of the date hereof, and will not, as of the applicable effective date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. 
 (j) Financial Statements. The financial statements included in the Registration Statement, together with
the related notes and schedules thereto, present fairly the consolidated financial position of the Company as of the dates indicated and the consolidated results of operations, cash flows and changes in shareholders’ equity of the Company for
the periods specified and have been prepared in compliance as to form in all material respects with the applicable accounting requirements of the Securities Act and the related rules and regulations adopted by the SEC and in conformity with United
States generally accepted accounting principles applied on a consistent basis during the periods involved. 
 (k) Investment Company.
The Company is not and, after giving effect to the offering and sale of the Purchased Shares, the consummation of the Offering and the application of the proceeds hereof and thereof, will not be an “investment company,” as such term is
defined in the U.S. Investment Company Act of 1940, as amended. 
 (l) Regulation S. No directed selling efforts (as defined in Rule
902 of Regulation S under the Securities Act) have been made by any of the Company, any of its affiliates or any person acting on its behalf with respect to any Purchased Shares that are not registered under the Securities Act; and none of such
persons has taken any actions that would result in the sale of the Purchased Shares to the Purchaser under this Agreement requiring registration under the Securities Act; and the Company is a “foreign issuer” (as defined in Regulation S).

  
 6 

 (m) Events Subsequent to Most Recent Fiscal Period. Since December 31, 2020
until the date hereof and to the Closing Date, there has not been any event, fact, circumstance or occurrence that has had or would reasonably be expected to have a Material Adverse Effect. 

(n) Solicitation. Neither the Company nor any person acting on its behalf has offered or sold the Purchased Shares by any form of
general solicitation or general advertising or directed selling efforts. 
 Section 2.2 Representations and Warranties of the
Purchaser. The Purchaser hereby represents and warrants, to the Company as follows: 
 (a) Due Formation. The Purchaser is duly
formed, validly existing and in good standing in the jurisdiction of its organization. The Purchaser has all requisite power and authority to carry on its business as it is currently being conducted. 

(b) Authority. The Purchaser has full power and authority to enter into, execute and deliver this Agreement and each agreement,
certificate, document and instrument to be executed and delivered by the Purchaser pursuant to this Agreement and to perform its obligations hereunder. The execution and delivery by the Purchaser of this Agreement and any agreements, certificates,
documents and instruments to be executed and delivered by the Purchaser pursuant to this Agreement, and the performance by the Purchaser of its obligations hereunder have been duly authorized by all requisite actions on its part. 

(c) Valid Agreement. This Agreement has been duly executed and delivered by the Purchaser and constitutes the legal, valid and binding
obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of
creditors’ rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. 

(d) Noncontravention. Neither the execution and the delivery of this Agreement, nor the consummation of the transactions contemplated
hereby, will (i) violate any provision of the organizational documents of the Purchaser or violate any constitution, statute, regulation, rule, injunction, judgment, order, decree, ruling, charge, or other restriction of any government,
governmental entity or court to which the Purchaser is subject, or (ii) conflict with, result in a breach of, constitute a default under, result in the acceleration of or creation of an encumbrance under, or create in any party the right to
accelerate, terminate, modify, or cancel, any agreement, contract, lease, license, instrument, or other arrangement to which the Purchaser is a party or by which the Purchaser is bound or to which any of the Purchaser’s assets are subject, in
each case of the foregoing (i) and (ii), in such a manner that would materially and adversely affect the Purchaser’s ability to consummate the transactions contemplated hereby. There is no action, suit or proceeding, pending or threatened
against the Purchaser that questions the validity of this Agreement or the right of the Purchaser to enter into this Agreement or to consummate the transactions contemplated hereby. 

  
 7 

 (e) Consents and Approvals. Neither the execution and delivery by the Purchaser of
this Agreement, nor the consummation by the Purchaser of any of the transactions contemplated hereby, nor the performance by the Purchaser of this Agreement in accordance with its terms requires the consent, approval, order or authorization of, or
registration with, or the giving notice to, any governmental or public body or authority or any third party, except such as have been or will have been obtained, made or given on or prior to the Closing Date. 

(f) Status and Investment Intent. 

(i) Experience. The Purchaser has sufficient knowledge and experience in financial and business matters so as to be
capable of evaluating the merits and risks of its investment in its Purchased Shares. The Purchaser is capable of bearing the economic risks of such investment, including a complete loss of its investment. 

(ii) Purchase Entirely for Own Account. The Purchaser is acquiring its Purchased Shares for its own account for
investment purposes only and not with the view to, or with any intention of, resale, distribution or other disposition thereof. The Purchaser does not have any direct or indirect arrangement, or understanding with any other persons to distribute, or
regarding the distribution of the Purchased Shares in violation of the Securities Act or any other applicable state securities law. 

(iii) Solicitation. The Purchaser (x) was not identified or contacted through the marketing of the Offering and
(y) did not contact the Company as a result of any general solicitation or directed selling efforts in the United States. 

(iv) Information. The Purchaser has been furnished access to all materials and information the Purchaser has requested
relating to the Company and its Subsidiaries and other due diligence documents in order to evaluate the transactions contemplated by this Agreement. The Purchaser has consulted to the extent deemed appropriate by the Purchaser with the
Purchaser’s own advisers as to the financial, tax, legal and related matters concerning an investment in its Purchased Shares. 

(v) Not U.S. Person. The Purchaser is not a “U.S. person” as defined in Rule 902 of Regulation S. 

(vi) Offshore Transaction. The Purchaser has been advised and acknowledges that in issuing Purchased Shares to the
Purchaser pursuant hereto, the Company is relying upon the exemption from registration provided by Regulation S. The Purchaser is acquiring its Purchased Shares in an offshore transaction in reliance upon the exemption from registration provided by
Regulation S. 
 (vii) FINRA. The Purchaser does not, directly or indirectly, own more than five per cent of the
outstanding common stock (or other voting securities) of any member of the Financial Industry Regulatory Authority, Inc. (“FINRA”) or a holding company for a FINRA member, and is not otherwise a “restricted person” for the
purposes of the Free-Riding and Withholding Interpretation of FINRA. 

  
 8 

 ARTICLE III 

COVENANTS 

Section 3.1 Lock-up. The Purchaser shall, at the Closing, enter into a lock-up agreement (the “Lock-up Agreement”) in the form set forth in Exhibit A hereto. 

Section 3.2 Distribution Compliance PeriodSection 3.3 . The Purchaser agrees not to resell, pledge or transfer any Purchased
Shares within the United States or to any U.S. Person, as each of those terms is defined in Regulation S, during the 40 days following the Closing Date. 

Section 3.3 Rule 144. The Company undertakes that during the period of one year after the Closing Date, the Company shall remain
as a “reporting issuer” for the purposes of Rule 144 of the Securities Act and shall satisfy the current public information requirement under Rule 144 of the Securities Act. The Company shall assist the Purchaser in converting the
Purchased Shares into the ADSs upon request of the Purchaser to the extent that such conversion is completed in compliance with Rule 144 of the Securities Act. 

Section 3.4 Further Assurances. From the date of this Agreement until the Closing Date, the Company and the Purchaser shall use
their commercially reasonable best efforts to fulfill or obtain the fulfillment of the conditions precedent to the consummation of the transactions contemplated hereby. 

ARTICLE IV 

INDEMNIFICATION 

Section 4.1 Indemnification. Each of the Company and the Purchaser (an “Indemnifying Party”) shall indemnify and
hold each other and their directors, officers, employees, advisors and agents (collectively, the “Indemnified Party”) harmless from and against any losses, claims, damages, fines, expenses and liabilities of any kind or nature
whatsoever, including but not limited to any investigative, legal and other expenses incurred in connection with, and any amounts paid in settlement of, any pending or threatened legal action or proceeding, and any taxes or levies that may be
payable by such person by reason of the indemnification of any indemnifiable loss hereunder (collectively, “Losses”) resulting from or arising out of: (a) the breach of any representation or warranty of such Indemnifying Party
contained in this Agreement or in any schedule or exhibit hereto; or (b) the violation or nonperformance, partial or total, of any covenant or agreement of such Indemnifying Party contained in this Agreement for reasons other than gross
negligence or willful misconduct of such Indemnified Party. In calculating the amount of any Losses of an Indemnified Party hereunder, there shall be subtracted the amount of any insurance proceeds and third-party payments received by the
Indemnified Party with respect to such Losses, if any. 

  
 9 

 Section 4.2 Third Party Claims. 

(a) If any third party shall notify any Indemnified Party in writing with respect to any matter involving a claim by such third party (a
“Third Party Claim”) which such Indemnified Party believes would give rise to a claim for indemnification against the Indemnifying Party under this Article IV, then the Indemnified Party shall promptly (i) notify the
Indemnifying Party thereof in writing within thirty (30) days of receipt of notice of such claim and (ii) transmit to the Indemnifying Party a written notice (“Claim Notice”) describing in reasonable detail the nature of
the Third Party Claim, a copy of all papers served with respect to such claim (if any), and the basis of the Indemnified Party’s request for indemnification under this Agreement. 

(b) Upon receipt of a Claim Notice with respect to a Third Party Claim, the Indemnifying Party shall have the right to assume the defense of
any Third Party Claim by, within thirty (30) days of receipt of the Claim Notice, notifying the Indemnified Party in writing that the Indemnifying Party elects to assume the defense of such Third Party Claim, and upon delivery of such notice by
the Indemnifying Party, the Indemnifying Party shall have the right to fully control and settle the proceeding, provided, that, any such settlement or compromise shall be permitted hereunder only with the written consent of the Indemnified
Party. 
 (c) If requested by the Indemnifying Party, the Indemnified Party shall, at the sole cost and expense of the Indemnifying Party,
cooperate with the Indemnifying Party and its counsel in contesting any Third Party Claim which the Indemnifying Party elects to contest, including the making of any related counterclaim against the person asserting the Third Party Claim or any
cross complaint against any person. The Indemnified Party shall have the right to receive copies of all pleadings, notices and communications with respect to any Third Party Claim, other than any privileged communications between the Indemnifying
Party and its counsel, and shall be entitled, at its sole cost and expense, to retain separate co-counsel and participate in, but not control, any defense or settlement of any Third Party Claim assumed by the
Indemnifying Party pursuant to Section 4.2(b). 
 (d) In the event of a Third Party Claim for which the
Indemnifying Party elects not to assume the defense or fails to make such an election within thirty (30) days of receipt of the Claim Notice, the Indemnified Party may, at its option, defend, settle, compromise or pay such action or claim at
the expense of the Indemnifying Party; provided, that, any such settlement or compromise shall be permitted hereunder only with the written consent of the Indemnifying Party, which consent shall not be unreasonably withheld or delayed. 

Section 4.3 Other Claims. In the event any Indemnified Party should have a claim against the Indemnifying Party hereunder which
does not involve a Third Party Claim, the Indemnified Party shall promptly transmit to the Indemnifying Party a written notice (the “Indemnity Notice”) describing in reasonable detail the nature of the claim, the Indemnified
Party’s best estimate of the amount of Losses attributable to such claim and the basis of the Indemnified Party’s request for indemnification under this Agreement. If the Indemnifying Party does not notify the Indemnified Party within
thirty (30) days from its receipt of the Indemnity Notice that the Indemnifying Party disputes such claim, the Indemnifying Party shall be deemed to have accepted and agreed with such claim. 

  
 10 

 Section 4.4 Cap. Notwithstanding the foregoing, except in cases involving fraud
or willful misconduct of any Indemnifying Party, an Indemnifying Party shall have no liability (for indemnification or otherwise) with respect to any Losses in excess of the applicable Purchase Price. 

ARTICLE V 

MISCELLANEOUS 

Section 5.1 Survival of the Representations and Warranties. All representations and warranties made by any Party hereto shall
survive for two (2) years and shall terminate and be without further force or effect on the second anniversary of the date hereof, except as to (i) any claims thereunder which have been asserted in writing pursuant to
Section 4.1 against the Party making such representations and warranties on or prior to such second anniversary, and (ii) the Company’s representations contained in Section 2.1(a),
(b), (c), (d) and (e) hereof, each of which shall survive indefinitely. 
 Section 5.2 Governing
Law; Arbitration. This Agreement shall be governed and interpreted in accordance with the laws of the State of New York without giving effect to the conflicts of law principles thereof. Any dispute arising out of or relating to this Agreement,
including any question regarding its existence, validity or termination (“Dispute”) shall be referred to and finally resolved by arbitration at the Hong Kong International Arbitration Centre in accordance with the Hong Kong
International Arbitration Centre Administered Arbitration Rules then in force. There shall be three arbitrators. Each Party has the right to appoint one arbitrator and the third arbitrator shall be appointed by the Hong Kong International
Arbitration Centre. The language to be used in the arbitration proceedings shall be English. The seat of arbitration shall be Hong Kong. Each of the Parties irrevocably waives any immunity to jurisdiction to which it may be entitled or become
entitled (including without limitation sovereign immunity, immunity to pre-award attachment, post-award attachment or otherwise) in any arbitration proceedings and/or enforcement proceedings against it arising
out of or based on this Agreement or the transactions contemplated hereby. 
 Section 5.3 Amendment. This Agreement shall not be
amended, changed or modified, except by another agreement in writing executed by the Parties. 
 Section 5.4 Binding Effect.
This Agreement shall inure to the benefit of, and be binding upon, the Purchaser, the Company, and their respective heirs, successors and permitted assigns. 

Section 5.5 Assignment. Neither this Agreement nor any of the rights, duties or obligations hereunder may be assigned by the
Company or the Purchaser without the express written consent of the other Party, except that a Purchaser may assign all or any part of its rights and obligations hereunder to any affiliate of the Purchaser without the consent of the Company,
provided that no such assignment shall relieve the Purchaser of its obligations hereunder if such assignee does not perform such obligations. Any purported assignment in violation of the foregoing sentence shall be null and void. 

  
 11 

 Section 5.6 Notices. All notices, requests, demands, and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given on the date of actual delivery if delivered personally to the Party to whom notice is to be given, on the date sent if sent by telecopier, tested telex or prepaid
telegram, on the next business day following delivery to Federal Express properly addressed or on the day of attempted delivery by the U.S. Postal Service if mailed by registered or certified mail, return receipt requested, postage paid, and
properly addressed as follows: 
  

			
	If to the Company, at:	  	 22/F, SCG Parkside, 868 Yinghua Road
 Pudong New
Area, Shanghai 201204
 People’s Republic of China
 E-mail: *******
 Attn: *******

		
	If to the Purchaser, at:	  	 Address: *******

E-mail: *******
 Attn:
*******

 Any Party may change its address for purposes of this Section 5.6 by giving
the other Party written notice of the new address in the manner set forth above. 
 Section 5.7 Entire Agreement. This Agreement
together with the Lock-up Agreement constitutes the entire understanding and agreement between the Parties with respect to the matters covered hereby, and all prior agreements and understandings, oral or in
writing, if any, between the Parties with respect to the matters covered hereby are merged and superseded by such agreements. 

Section 5.8 Severability. If any provisions of this Agreement shall be adjudicated to be illegal, invalid or unenforceable in any
action or proceeding whether in its entirety or in any portion, then such provision shall be deemed amended, if possible, or deleted, as the case may be, from the Agreement in order to render the remainder of the Agreement and any provision thereof
both valid and enforceable, and all other provisions hereof shall be given effect separately therefrom and shall not be affected thereby. 

Section 5.9 Fees and Expenses. Except as otherwise provided in this Agreement, the Company and the Purchaser will bear their
respective expenses incurred in connection with the negotiation, preparation and execution of this Agreement and the transactions contemplated hereby, including fees and expenses of attorneys, accountants, consultants and financial advisors. 

Section 5.10 Confidentiality. Each Party shall keep in confidence, and shall not use (except for the purposes of the transactions
contemplated hereby) or disclose, any non-public information disclosed to it or its affiliates, representatives or agents in connection with this Agreement or the transactions contemplated hereby. Each Party
shall ensure that its affiliates, representatives and agents keep in confidence, and do not use (except for the purposes of the transactions contemplated hereby) or disclose, any such non-public information.

  
 12 

 Section 5.11 Specific Performance. The Parties agree that irreparable damage
would occur in the event any provision of this Agreement were not performed in accordance with the terms hereof and that the Parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or equity.

 Section 5.12 Termination. In the event that the Closing shall not have occurred by [June 30, 2022], the Company or Purchaser
(with respect to itself) may terminate this Agreement with no further force or effect, except for the provisions of Article V, which shall survive any termination under this Section 5.12, provided that no
party who is then in a material breach of this Agreement shall not be entitled to terminate this Agreement. 
 Section 5.13
Description of Purchaser. 
 (a) The Purchaser hereby consents and undertakes to promptly provide a description of its organization
and business activities to the Company (the “Purchaser Description”) to be used solely in the Registration Statement and the prospectus therein, and hereby represents that its Purchaser Description will be true and accurate in all
material respects and will not be misleading in any material respect. 
 (b) The Purchaser hereby agrees and consents to the use of and
references to its name, the inclusion of Purchaser Description, the disclosure of the transactions contemplated under this Agreement and the filing of this Agreement as an exhibit to the Registration Statement and other SEC filings, marketing
materials and other publicity materials in connection with the Offering. 
 (c) The Purchaser acknowledges that the Company will rely upon
the truth and accuracy of its Purchaser Description, and it agrees to notify the Company promptly in writing if any of the content contained therein ceases to be accurate and complete or becomes misleading. 

Section 5.14 Headings. The headings of the various articles and sections of this Agreement are inserted merely for the purpose of
convenience and do not expressly or by implication limit, define or extend the specific terms of the section so designated. 

Section 5.15 Execution in Counterparts. For the convenience of the Parties and to facilitate execution, this Agreement may be
executed in one or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute but one and the same instrument. 

Section 5.16 No Waiver. Except as specifically set forth herein, the rights and remedies of the parties to this Agreement are
cumulative and not alternative. No failure or delay on the part of any Party in exercising any right, power or remedy under this Agreement will operate as a waiver of such right, power or remedy, and no single or partial exercise of any such right,
power or remedy will preclude any other or further exercise of such right, power or remedy or the exercise of any other right, power or remedy. To the maximum extent permitted by applicable law, (a) no claim or right arising out of this
Agreement can be discharged by one Party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing signed by the other Party; (b) no waiver that may be given by a Party will be applicable except in the specific
instance for which it is given; and (c) no notice to or demand on one Party will be deemed to be a waiver of any obligation of that Party or of the right of the Party giving such notice or demand to take further action without notice or demand
as provided in this Agreement. 

  
 13 

 [Signature pages follow] 

  
 14 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the
day and year first above written. 
  

			
	Soulgate Inc.
		
	By:	 	 /s/ Lu Zhang

	Name:	 	Lu Zhang
	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the
day and year first above written. 
  

			
	MIHOYO LIMITED
		
	By:	 	 /s/ Wei Liu

	Name:	 	Wei Liu
	Title:	 	Director

 Schedule A 

Authorized Share Capital 
 As of the date hereof,
our authorized share capital is US$100,000 divided into 1,000,000,000 ordinary shares, comprising of (i) 840,000,000 Class A ordinary shares with a par value of US$0.0001 each, (ii) 60,000,000 Class B ordinary shares with a par value of
US$0.0001 each, and (iii) 100,000,000 shares with a par value of US$0.0001 each of such class or classes (however designated) as our board of directors may determine (which shall include the approval of director appointed by Image Frame Investment
(HK) Limited (“Tencent”), so long as Tencent is entitled to appoint one director). 
 Issued and Outstanding Shares 

As of the date hereof, 116,104,370 Class A ordinary shares and 35,814,050 Class B ordinary shares are issued and outstanding. 

 Exhibit A 

Lock-up LetterPredictmedix Inc.: Exhibit 4.1 - Filed by newsfilecorp.com

    

    

    PREDICTMEDIX INC.

    (formerly Cultivar Holdings Inc., the "Company")

    
Amended and Restated 

    Incentive Stock Option Plan
 

    September 2019

     1. PURPOSE OF THE PLAN

    1.1 Purpose of Plan. This Incentive Stock Option Plan has been established by the Company for the following purposes:

    (a) to promote the commitment of employees, directors, officers and consultants to the Company;

    (b) to reward employees, directors, officers and consultants for past loyalty and accomplishments;

    (c) to focus employees, directors, officers and consultants on increasing the overall value of the Company for the benefit of the Company and its shareholders; and

    (d) to reduce compensation and benefits demands on the Company from employees, directors, officers and consultants.

     2. DEFINED TERMS

    2.1 Definitions. Where used in this Plan, the following terms shall have the following meanings:

    "Board" means the board of directors of the Company, or any committee of the board of directors to which the duties of the board of directors hereunder are delegated.

    "Business Day" means any day on which the Company's bank is ordinarily open for business in the City of Toronto, Ontario, provided such day is not a Saturday or Sunday.

    "Company" means Predictmedix Inc. and includes any successor corporation thereto.

    "Consultant" means an individual, other than an employee or an executive of the Company, that: (a) is engaged to provide consulting, technical, management, professional or other bona fide services to the Company or to an affiliate of the Company, under a written contract or retainer agreement between the Company or the affiliate and the individual, or a company of which the individual consultant is an employee and shareholder; and (b) spends or will spend significant amount of time and attention on the affairs and business of the Company or an affiliate of the Company in the reasonable opinion of the Board.

    

    
        2

    

    "Date of Grant" means the date of approval of a Grant of Options in accordance with the terms of the Plan.

    "Director" means an individual who is a director of the Company.

    "Earliest Exercise Date" means the earliest date on which a Participant can exercise an Option, as set out in the Grant.

    "Eligible Person" means all full-time employees of the Company and its affiliates, all Consultants to the Company and its affiliates, and all Directors of the Company and its affiliates.

    "Exchange" means the Canadian Securities Exchange or any other stock exchange on which the Shares are listed.

    "Exercise Price" means the price per share at which Shares may be purchased upon exercise of the Option, as it may be adjusted from time to time in accordance with the provisions of the Plan.

    "Expiry Date" means the latest date on which a Participant can exercise an Option, as set out in the Grant.

    "Grant" means a written grant of an Option by the Company to an Eligible Person issued in accordance with the Plan, in the form attached hereto as Schedule "A".

    "Market Price" means the closing trading price of the Shares on the Exchange on the day immediately preceding the relevant date.

    "Option" means a right granted under the Plan to an Eligible Person to purchase Shares in accordance with the Plan.

    "Optioned Shares" means the Shares into which Options granted to an Eligible Person may be exercised, as set out in the Grant.

    "Participant" means an Eligible Person to whom an Option has been granted in accordance with the terms of the Plan.

    "Plan" means this Predictmedix Inc. Amended and Restated Incentive Stock Option Plan, as set out herein, and as it may be amended or varied from time to time.

    "Policies" means such policies approved by the Board from time to time with respect to the Optioned Shares and the Plan.

    "Share Option Pool" means the aggregate number of Shares reserved by the Company for issuance under this Plan, which will not exceed ten percent (10%) of the number of issued shares of the Company at the time of the granting of options under the Plan.

    

    
        3

    

    "Shares" means the common shares of the Company, as currently constituted, or, in the event of an adjustment contemplated hereunder, such other shares or securities to which a Participant may be entitled upon the exercise of an Option as a result of such adjustment.

    "Tax Act" means the Income Tax Act (Canada).

    "Vesting Requirements" means any conditions precedent that must be satisfied before a Participant may exercise an Option granted pursuant to the Plan, which conditions may include criteria related to the performance of the Company, the performance of the Participant, completion of a triggering event, or such other criteria as the Board in its discretion may deem appropriate.

     3. ESTABLISHMENT AND ADMINISTRATION OF THE PLAN

    3.1 Plan Established. The Company hereby establishes the Plan in accordance with the terms set out herein and any resolution passed by the Board in respect hereto.

    3.2 Name of Plan. The Plan shall be known as the Cultivar Holdings Inc. Incentive Stock Option Plan.

    3.3 Administrator of Plan. The Plan shall be administered by the Board in its discretion, but subject to the terms and conditions of this Plan. Any reference in this Plan to an action taken or to be taken by the Company, or a decision made or to be made by the Company, shall mean an action or decision made by or under the authority of the Board or any person or committee that has been designated for that purpose by the Board as confirmed by resolution of the Board.

    3.4 Amendment of Plan. The Board may in its discretion amend or discontinue the Plan at any time, provided, however, that no such amendment may alter or impair any Option previously granted to a Participant under the Plan (or any Shares issued upon the exercise of such Option) without the consent of the Participant.

    3.5 Term of Plan. The Plan shall commence immediately upon approval of the Plan by the Board, and shall terminate by resolution of the Board; provided that no such termination shall amend, suspend or terminate any Option previously granted to a Participant under the Plan (or any Shares issued upon the exercise of such Option) without the consent of the Participant.

    3.6 Policies. The Board may, in its discretion, prepare and issue Policies to guide it in administering the Plan and granting Options, provided such Policies shall not be binding upon the Board or limit its discretion, but shall be documents of general guidance only. The Board may amend, vary, suspend or terminate the Policies from time to time in its absolute discretion, provided that no such amendment, variance, suspension or termination shall amend, suspend or terminate any Option previously granted to a Participant under the Plan (or any Shares issued upon the exercise of such Option) without the consent of the Participant.

    3.7 Powers of the Board. In addition to the other powers of the Board set out in this Plan, the Board shall have the power, where consistent with the general purpose and intent of the Plan and subject to the specific provisions of the Plan:

    

    
        4

    

    (a) to interpret and construe the Plan and to determine all questions arising out of the Plan and any Option granted pursuant to the Plan, and any such interpretation, construction or termination made by the Board shall be final, binding and conclusive for all purposes;

    (b) to determine which Eligible Person, if any, is to receive Options,

    (c) to grant Options;

    (d) to determine the number of Optioned Shares into which each Option may be exercised;

    (e) to determine the Exercise Price;

    (f) to determine the time or times when Options will be granted and exercisable;

    (g) to determine if the Shares that are subject to an Option will be subject to any restrictions upon the exercise of such Option; and

    (h) to prescribe the form of the instruments relating to the grant, exercise and other terms of Options.

     4. SHARES SUBJECT TO PLAN

    4.1 Shares. Options may be granted in respect of authorized and unissued Shares out of the Share Option Pool. Shares in respect of which Options are cancelled, terminated or not exercised prior to expiry shall be available for issuance out of the Share Option Pool pursuant to subsequent Options under the Plan. No fractional shares may be purchased or issued under the Plan.

    4.2 No Obligation to Grant Options. The Company is in no way bound or committed to grant Options equal to the maximum number of Shares which may be issued pursuant to the Plan.

     5. ELIGIBILITY, GRANT AND TERMS OF OPTIONS

    5.1 Grant to Eligible Persons Only. An Option may be granted only to an Eligible Person.

    5.2 Options Non-Assignable. An Option is personal to the Participant and is non-assignable.

    5.3 Grant of Options. From time to time, the Company may grant an Option to an Eligible Person to acquire Shares in accordance with the Plan. In granting such Option, the Company shall designate:

    (a) the number of Optioned Shares that the Participant may purchase under the Option;

    (b) the Earliest Exercise Date on which the Option may be exercised;

    

    
        5

    

    (c) the Expiry Date after which the Option may not be exercised.

    (d) the Exercise Price at which the Participant may purchase Shares upon the exercise of the Option;

    (e) any Vesting Requirements that must be satisfied before a Participant may exercise the Option;

    (f) the latest date by which any Vesting Requirements must be satisfied; and

    (g) any other terms, conditions and provisions relating to such Option as determined by the Board in its discretion.

    5.4 Exercise Price. The Exercise Price at which a Participant may purchase Optioned Shares upon the exercise of an Option granted pursuant to the Plan shall in no circumstances be lower than the Market Price of the Shares as at the date of the grant of the Option.

    5.5 Expiry Date. The Expiry Date on Options granted shall not be longer than ten (10) years, provided that such Expiry Date may be extended by resolution of the Board.

    Notwithstanding the foregoing, in the event that the Expiry Date fall within, or within two (2) days of, a trading blackout period imposed by the Company (the "Blackout Period"), the Expiry Date shall be automatically extended to the 10th business day following the end of the Blackout Period.

    5.6 Determination of Vesting Requirements. Subject to the terms of the Plan, the Company shall in its sole discretion determine whether and when the Vesting Requirements have been satisfied and any decision of the Company in this regard shall be final and binding.

     6. EXERCISE OF OPTIONS

    6.1 Exercise of Options. Subject to the provisions of the Plan and the provisions of the Grant, an Option may be exercised by the Participant (subject to the other requirements set out in this Plan) only on or after the Earliest Exercise Date and only if all Vesting Requirements have been satisfied prior to the deadline for the completion of such Vesting Requirements as set out in the Grant.

    6.2 Number of Optioned Shares for which Option Exercised. Unless the Company shall otherwise agree in writing:

    (a) the maximum number of Optioned Shares that the Participant may purchase under the Option during each calendar year of the Company or part thereof shall be as set out in the Grant; and

    (b) if the number of Optioned Shares purchased under the Option during any calendar year of the Company or part thereof is less than the maximum number which could have been purchased under the Option during such calendar year of the Company or part thereof, the difference shall be carried forward and added to the maximum number of Optioned Shares that may be purchased under the Option in the immediately following calendar year of the Company, and so on from time to time.

    

    
        6

    

    6.3 Participant May Delay Exercising Options: A Participant shall not be required to exercise an Option on the Earliest Exercise Date or at any time prior to the Expiry Date, and shall not be penalized for failing to exercise an Option; provided that all Options are subject to the provisions of the Grant of such Options and this Plan and may terminate or otherwise expire if not exercised prior to the deadlines therein set out.

    6.4 Exercise of Options.  Unless the Grant of an option provides otherwise, the exercise of an Option under the Plan shall be made by delivery to the Company at its registered office of a written notice of exercise, addressed to the Company, specifying the number of Optioned Shares with respect to which the Option is being exercised, and accompanied by a certified cheque or bank draft payable to the Company representing payment in full of the aggregate Exercise Price for the Optioned Shares in respect to which the Option is exercised. As of the day on which the Company receives notice of the exercise of an Option by a Participant, the Participant shall be entitled to be entered on the share register of the Company as the holder of the number of Shares in respect to which the Option is exercised and for which full payment of the aggregate Exercise Price has been made and a certificate or certificates for such Shares shall be issued and delivered to the Participant by the Company within a reasonable time following the receipt by the Company of such notice and payment.

    6.5 Shares Held in RRSPs. The Company shall permit Participants to direct that their Shares be held by the Participant's Registered Retirement Savings Plan, provided:

    (a) it is otherwise permitted by law; and

    (b) all regulatory requirements applicable to such holding are satisfied as to form and substance.

     7. TERMINATION OF UNEXERCISED OPTIONS

    7.1 General. For all Participants, unless the Grant provides otherwise or the Company otherwise agrees in writing, all unexercised Options and all Grants shall automatically terminate and expire on the Expiry Date thereof and may not thereafter be exercised by the Participant.

    7.2 Death. For all Participants, all unexercised Options and all Grants shall terminate and expire ninety (90) days after the death of the Participant, provided that during such ninety (90) day period the Participant's estate shall be entitled to exercise all Options for which all applicable Vesting Requirements have been satisfied as set out in the relevant Grant, or in respect to which all applicable Vesting Requirements will have been satisfied, as set out in the relevant Grant, within such ninety (90) day period after the death of the Participant.

    7.3 Disability. For all Participants, upon the mental or physical disability of the Participant such that the Participant cannot continue to perform his or her then current functions with the Company, as determined by the Company in its absolute discretion, on written notice to the Participant:

    

    
        7

    

    (a) all Grants and all unexercised Options shall be suspended, but not revoked, until the disability has ended and the Participant can resume his or her then current functions with the Company, as determined by the Company in its absolute discretion; and

    (b) if the disability continues for more than ninety (90) days, or re-occurs for more than ninety (90) cumulative days in any one-hundred and eighty (180) day period, as determined by the Company in its absolute discretion, on written notice to the Participant the Company may at its option terminate the Grant and all unexercised Options shall expire as of the date of the Company's notice.

    7.4 Retirement. For all Participants, all unexercised Options and all Grants shall immediately terminate and expire as of the effective date of the resignation or retirement of the Participant from the Company.

    7.5 Termination for Cause. If the employment of a Participant is terminated by the Company or its affiliate for cause, all unexercised Options and all Grants shall immediately terminate and expire as of the effective date of termination of the Participant's employment.

    7.6 Termination without Cause. If the employment of a Participant is terminated by the Company or its affiliate without cause, and such termination is not the result of the death, disability, retirement or resignation of the Participant (in which case the provisions above shall apply), all unexercised Options and all Grants shall terminate and expire thirty (30) days after the effective date of termination of the Participant's employment, provided that the effective date of termination of the Participant's employment shall be the last day on which the Participant has full-time employment responsibilities with the Company or an affiliate (regardless of any severance payment made by the Company, any payment in lieu of notice made by the Company, or any notice period determined by a court, arbitrator or tribunal in the event that the employer and the employee cannot agree on the length of the relevant notice period to which such Participant is entitled).

    7.7 Directors. For those Participants who are Directors, and unless the Grant of Options states otherwise, all unexercised Options and all Grants shall immediately terminate and expire as of the effective date of the removal from office of such Director, except in the case of the death of a Director, in which case the provisions of section 7.2 shall apply.

    7.8 Consultants. For those Participants who are Consultants, all unexercised Options and all Grants shall immediately terminate and expire as follows:

    (a) if the Consultant shall commit a material breach or default pursuant to the contract for services between the Consultant and the Company, on the later of: (i) the date of commission of such material breach or default; and (ii) the date upon which the Company learns of the material breach or default;

    (b) if the Consultant's contract is terminated by either the Company or the Consultant without cause, on the effective date of the notice of termination as issued by the Company or the Consultant, as the case may be; or

    

    
        8

    

    (c) if the contract for services between the Consultant and the Company is terminated by the Consultant by virtue of a material breach or default committed by the Company, on the issuance of a notice of termination of such contract by the Consultant, without prejudice to any claim of the Consultant for damages as against the Company for breach of contract including damages for loss of any unexercised Options.

    7.9 Insolvency. For all Participants, all unexercised Options and all Grants shall immediately expire and terminate immediately upon the Participant being adjudged bankrupt, making an assignment in bankruptcy, making an assignment for the general benefit of the Participant 's creditors, commencing proceedings under the Companies' Creditors Arrangement Act, or having all of its assets or the Options or any Shares seized by any creditor or anyone on behalf of any creditor including any sheriff, bailiff or other officer of any court.

    7.10 Impossibility of Vesting Requirements. For all Participants, all unexercised Options and all Grants shall immediately expire and terminate as of the date upon which it becomes impossible for the Participant to satisfy the Vesting Requirements, as determined by the Company acting in good faith and without the requirement for prior written notice.

    7.11 Change of Duties. Options shall not be affected by any change of employment of the Participant or by the Participant ceasing to be a Director, officer or employee, where the Participant otherwise continues to be an Eligible Person.

     8. TRANSFER OF OPTIONS

    8.1 Transfer of Options. Options are personal to the Participant and are not transferable or assignable in any way for any reason. No Participant shall transfer, assign, hypothecate, mortgage, charge, grant a security interest in or in any other way attempt to dispose of or alienate his or her Options.

     9. ANTI-DILUTION ADJUSTMENTS

    9.1 Anti-Dilution Adjustments. Subject to sections 9.2 and 9.3 of this Plan, the number of Shares deliverable upon the exercise of an Option shall be subject to adjustment in each of the following circumstances, and such adjustments shall be cumulative:

    (a) Subdivision. In the event of any subdivision or subdivisions of the Shares of the Company as such Shares are constituted on the date of Grant of an Option, at any time while such Option is in effect, into a greater number of Shares, the Company shall thereafter deliver at the time of purchase of Shares pursuant to the Option, in addition to the number of Shares for which the right to purchase is then being exercised, the additional number of Shares as result from the subdivision or subdivisions without the Participant making any additional payment or giving any other consideration therefore.

    (b) Consolidation: In the event of any consolidation or consolidations of the Shares of the Company as Shares are constituted on the date of Grant of an Option, at any time while such Option is in effect, into a lesser number of Shares, the Company shall thereafter deliver and the Participant shall accept, at the time of purchase of Shares pursuant to the Option, in lieu of the number of Shares for which the right to purchase is then being exercised, the lesser number of Shares as result from the consolidation or consolidations.

    

    
        9

    

    (c) Change of Shares: In the event of any change to the Shares of the Company as such Shares are constituted on the date of Grant of an Option, at any time while such Option is in effect, the Company shall thereafter deliver at the time of purchase of Shares purchase of Shares pursuant to the Option, the number of securities of the appropriate class resulting from the change as the Participant would have been entitled to receive for the number of Shares so purchased had the Option been exercised before such change.

    (d) Reorganization: In the event of any capital reorganization, reclassification or change of outstanding equity shares of the Company, or in the event of any consolidation, merger or amalgamation of the Company with or into any other company, or in the event of any sale of the property of the Company as or substantially as an entity, at any time while any Option is in effect (collectively, a "reorganization"), the Participant shall thereafter have the right to purchase, instead of the Shares that previously could have been purchased upon the exercise of the Option, the kind and amount of shares and other securities and property receivable upon the reorganization which the holder of a number of Shares equal to the number of Shares that previously could have been purchased upon the exercise of the Option would have received as a result of the reorganization. A subdivision or consolidation of Shares at any time outstanding into a greater or lesser number of Shares shall be deemed not to be a reorganization for the purpose of this subsection.

    9.2 No Fractional Shares. The Company shall not be required to issue fractional shares in satisfaction of its obligations under this Plan. Any fractional interest in a Share that would, except for the provisions of this section, be delivered upon the exercise of an Option, shall be cancelled and not be deliverable by the Company.

    9.3 No Obligation to Make Loan. The Company shall in no way be obligated or required to loan money to a Participant to enable such Participant to exercise an Option or pay an Exercise Price to receive Shares.

     10. ACCOUNTS, RECORDS, TAXES AND NOTICE

    10.1 Accounts and Records. The Company shall maintain records of the details of each Option granted to each Participant under the Plan, including the date of Grant, the number of Shares into which each Option may be exercised, any applicable Vesting Requirements and the Exercise Price per Share. The Company shall also maintain records of each Option exercised, the number of Shares issued in respect to the exercise of each exercised Option, and the maximum number of Shares which the Participant may still purchase under the Option. Upon request from a Participant and at such other time as the Company shall determine, the Company shall furnish the Participant with a statement setting forth the details of the Participant's Options (as described above) with such other or additional information as the Company may deem appropriate. Such statement shall be deemed to have been accepted by the Participant as correct unless written notice to the contrary is given to the Company within five (5) Business Days after such statement is given to the Participant.

    

    
        10

    

    10.2 Income Taxes. For certainty and notwithstanding any other provision of the Plan, the Company or any may take such steps as it considers necessary or appropriate for the deduction or withholding of any income taxes or other amounts which the Company is required by any law, or regulation of any governmental authority whatsoever, to deduct or withhold in connection with the Plan, including, without limiting the generality of the foregoing, (a) withholding of all or any portion of any amount otherwise owing to a Participant; (b) the suspension of the issue of Shares to be issued under the Plan, until such time as the Participant has paid to the Company an amount equal to any amount which the Company is required to deduct or withhold by law with respect to such taxes or other amounts; and/or (c) withholding and causing to be sold, by it as an agent on behalf of a Participant, such number of Shares as it determines to be necessary to satisfy the withholding obligation. By participating in the Plan, the Participant consents to such sale and authorizes the Company to effect the sale of such Shares on behalf of a Participant and to remit the appropriate amount to the applicable governmental authorities. The Company shall not be responsible for obtaining any particular price for the Shares nor shall the Company be required to issue any Shares under the Plan unless the Participant has made suitable arrangements with the Company to fund any withholding obligation.

    10.3 Notice to Participant. Any payment, notice, statement, certificate or other instrument required or permitted to be given to a Participant or any person claiming or deriving any rights through a Participant shall be given by delivering it personally to the Participant or to the person claiming or deriving rights through the Participant, as the case may be, or by mailing it postage paid (provided that the postal service is then in operation) or delivering it to the address which is maintained for the Participant in the Company's personnel records.

    10.4 Notice to the Company. Any payment, notice, statement, certificate or instrument required or permitted to be given to the Company shall be given by mailing it postage prepaid (provided that the postal service is then in operation) or delivering it to the Company at either the Company's principal place of business or the Company's registered office, marked to the attention of the Secretary of the Company.

    10.5 Receipt of Notice. Any payment, notice, statement, certificate or other instrument given pursuant to sections 10.3 or 10.4, if delivered, shall be deemed to have been delivered and received on the date o)n which it was delivered or, if mailed (provided that the postal service is then in operation), shall be deemed to have been delivered and received on the fifth (5th) Business Day following the date on which it was mailed.

     11. MISCELLANEOUS PROVISIONS

    11.1 Company Decisions Final and Binding. The determination by the Company of any question which may arise as to the interpretation or implementation of the Plan or any of the Options granted hereunder shall be final and binding.

    

    
        11

    

    11.2 Enurement. This Plan shall enure to the benefit of and be binding upon the Company, its successors and assigns. The interest of any Participant under this Plan shall be not transferable or alienable by pledge, assignment or in any other manner whatsoever and, during the lifetime of the Participant, shall be vested only in the Participant, but shall thereafter enure to the benefit of and be binding upon the legal personal representatives of such Participant, in the event of his or her death.

    11.3 Statutory Compliance. The obligation of the Company to issue Shares in accordance with the terms of this Plan and any Option granted hereunder is subject to compliance with the laws, rules and regulations of all public and regulatory agencies and authorities applicable to the issuance and distribution of such Shares. As a condition of participating in the Plan, each Participant agrees to comply with all such laws, rules and regulations and agrees to furnish to the Company all information and undertakings as may be required to permit compliance with such laws, rules and regulations.

    11.4 Rights. The holder of an Option shall not have any rights as a shareholder of the Company whatsoever with respect to any of the Shares underlying such Option, until the Participant shall have exercised such Option in accordance with the terms of the Plan and tendered full payment of the Exercise Price of the Shares in respect of which the Option is exercised.

    11.5 No Guarantee of Association. Nothing in the Plan or any Option, nor the issuance of a Grant or its acceptance, shall in any way confer upon any Participant any right to continue providing services or be in the employ of the Company or any affiliate of the Company, whether as employee, Consultant, Director or otherwise, or affect in any way the right of the Company or its affiliate to terminate his or her employment or service agreement at any time; nor shall anything in the Plan or any Option be deemed or construed to constitute an agreement, or an expression of intent, on the part of the Company or any affiliate of the Company to extend the employment or service agreement of any Participant beyond the time that he or she would normally be retired pursuant to the provisions of any present or future retirement plan or policy of the Company or any affiliate, or beyond the time at which he or she would otherwise be retired pursuant to the provisions of any contract of employment or service with the Company or its affiliate.

    11.6 Confidentiality. The Participant agrees that all financial statements and other confidential Company information received by the Participant in his or her capacity as a Participant, Option holder or shareholder, shall be kept strictly confidential, and shall not be disclosed to anyone other than the Participant's professional or financial advisors who in tum shall hold this information in confidence. This obligation does not apply to information that the Company makes generally available to the public, or which comes into the public domain through no fault of the Participant. This obligation is in addition to, and not in substitution for, any obligations of confidentiality owed by a Participant to the Company by way of written agreement or otherwise.

    11.7 Interpretation. The Plan will be governed by and construed in accordance with the laws in effect in the Province of Ontario and the laws of Canada applicable in the Province of Ontario.

    

    
        12

    

    11.8 Compliance with Applicable Law. If any provision of the Plan or any Option contravenes any law or any order, policy, by-law or regulation of any regulatory body or stock exchange having authority over the Company or the Plan, then such provision shall be deemed to be amended to the extent required to bring such provision into compliance therewith.

    

    
        13

    

    SCHEDULE "A"

    to Stock Option Plan

     

    PREDICTMEDIX INC.

    STOCK OPTION PLAN
 

     

    OPTION AGREEMENT

    This Option Agreement is entered into between Predictmedix Inc. (the "Company") and the Optionee named below pursuant to the Stock Option Plan (the "Plan"), and confirms that:

    1. on __________________, ___________;

    2. _________________________________ (the "Optionee");

    3. was granted the option to purchase ________________ common shares (the "Optioned Shares") of the company;

    4. for the price of $ ________ per Optioned Share;

    5. exercisable from time to time up but not after __________________, ___________, and pursuant to section 5.3 of the Plan, subject to the following Vesting Schedule:

    [Insert Vesting Schedule];

    all on the terms and subject to the conditions set out in the Plan.

    By signing this Option Agreement, the Optionee acknowledges that the Optionee has read and understands the Plan and agrees to the terms and condition of the Plan and this Option Agreement.

    IN WITNESS WHEREOF the parties hereto have executed this Option Agreement as of the ____ day of __________________, ___________.

     

    	 	 	 	PREDICTMEDIX INC.
	 	 	 	 
	 	 	 	 
	 	 	By:	 
	Optionee	 	 	(Authorized Signatory)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]